Studies from University of Sao Paulo (USP) in the Area of Gliomas Described (Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial).

Předmět:	DENDRITIC cells GLIOMAS OVERALL survival VACCINATION RETICULO-endothelial system IMMUNOTHERAPY BRAIN tumors
Zdroj:	Immunotherapy Weekly; 3/6/2023, p1378-1378, 1p
Abstrakt:	For more information on this research see: Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial. Keywords: Antigen-Presenting Cells; Cancer; Clinical Research; Clinical Trials and Studies; Dendritic Cells; Drugs and Therapies; Glioblastomas; Gliomas; Health and Medicine; Immunization; Immunology; Immunotherapy; Mononuclear Phagocyte System; Oncology; Public Health; Vaccination EN Antigen-Presenting Cells Cancer Clinical Research Clinical Trials and Studies Dendritic Cells Drugs and Therapies Glioblastomas Gliomas Health and Medicine Immunization Immunology Immunotherapy Mononuclear Phagocyte System Oncology Public Health Vaccination 1378 1378 1 03/24/23 20230306 NES 230306 2023 MAR 6 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators publish new report on gliomas. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu